Ofri Mosenzon Selected Research

Ofri Mosenzon Research Topics

Disease

64	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2013
33	Myocardial Infarction 01/2022 - 10/2013
28	Heart Failure 01/2022 - 10/2013
19	Diabetes Mellitus 11/2021 - 10/2014
15	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2016
11	Ischemic Stroke 01/2022 - 06/2015
9	Chronic Renal Insufficiency 01/2022 - 10/2014
9	Kidney Diseases (Kidney Disease) 01/2022 - 01/2018
7	Weight Loss (Weight Reduction) 01/2022 - 01/2018
7	Hypoglycemia (Reactive Hypoglycemia) 10/2021 - 08/2016
6	Obesity 01/2022 - 01/2018
6	Stroke (Strokes) 01/2022 - 10/2013
6	Body Weight (Weight, Body) 01/2022 - 11/2020
5	Albuminuria 01/2021 - 04/2015
4	Overweight 01/2022 - 01/2020
4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 01/2017
4	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2021 - 01/2019
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 11/2014
3	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2020
3	Nausea 01/2022 - 01/2018
3	Body Weight Changes 04/2021 - 01/2020
3	Atrial Fibrillation 01/2021 - 11/2019
3	Pancreatitis 11/2020 - 10/2013
3	Infections 01/2020 - 01/2019
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2019
2	Glycosuria 10/2021 - 01/2018
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2021 - 11/2020
2	Renal Insufficiency (Renal Failure) 01/2018 - 08/2016
2	Chronic Pancreatitis 09/2014 - 10/2013
1	Constipation 01/2022
1	Vomiting 01/2022
1	Asthma (Bronchial Asthma) 11/2021
1	Insulin Resistance 10/2021
1	Coma (Comas) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Thyroid Neoplasms (Thyroid Cancer) 11/2020
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 11/2020
1	Urologic Neoplasms (Urological Cancer) 01/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Peripheral Arterial Disease 01/2020
1	Ventricular Remodeling 01/2020
1	Neoplasms (Cancer) 01/2020
1	Weight Gain 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2019
1	Hypersensitivity (Allergy) 01/2019
1	Anaphylaxis (Anaphylactic Shock) 01/2019

Drug/Important Bio-Agent (IBA)

25	dapagliflozinIBA 01/2022 - 01/2018
21	saxagliptin FDA Link 11/2021 - 10/2013
18	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2016
13	Liraglutide FDA Link 01/2022 - 01/2018
12	SodiumIBA 01/2022 - 01/2018
10	semaglutideIBA 01/2022 - 01/2018
10	Sodium-Glucose Transport ProteinsIBA 01/2021 - 01/2019
9	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2018
8	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2018
7	Insulin (Novolin)FDA Link 04/2021 - 11/2014
6	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 01/2018
6	CreatinineIBA 01/2022 - 01/2018
6	Biomarkers (Surrogate Marker)IBA 11/2021 - 12/2016
6	Metformin (Glucophage)FDA LinkGeneric 04/2021 - 01/2019
6	Pharmaceutical PreparationsIBA 10/2020 - 08/2016
5	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 12/2018
5	AlbuminsIBA 01/2022 - 01/2018
5	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 01/2018
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 01/2020
3	pro-brain natriuretic peptide (1-76)IBA 11/2021 - 01/2018
3	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2021 - 10/2014
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021 - 08/2016
2	Troponin T (Troponin T1)IBA 11/2021 - 12/2016
2	TicagrelorIBA 01/2021 - 01/2021
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2021
2	DiureticsIBA 01/2020 - 11/2016
1	LDL CholesterolIBA 01/2022
1	HDL LipoproteinsIBA 01/2022
1	HDL CholesterolIBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	PotassiumIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	ORALIT (ORS)IBA 11/2021
1	empagliflozinIBA 10/2021
1	Sitagliptin Phosphate (Januvia)FDA Link 04/2021
1	Peptides (Polypeptides)IBA 04/2021
1	darapladibIBA 01/2021
1	Thyroid HormonesIBA 01/2021
1	Factor Xa (Coagulation Factor Xa)IBA 01/2021
1	SymportersIBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2020
1	lixisenatideIBA 01/2019
1	Exenatide (Byetta)FDA Link 01/2019

Therapy/Procedure

11	Therapeutics 10/2021 - 01/2003
4	Glycemic Control 11/2020 - 01/2017
3	Surgical Amputation (Amputations) 01/2022 - 01/2020
3	Secondary Prevention 01/2021 - 01/2018
1	Withholding Treatment 01/2021
1	Psychology Biofeedback (Biofeedback) 01/2021
1	Precision Medicine 12/2020
1	Contraindications 10/2020
1	Kidney Transplantation 01/2019